Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Lyrica
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lyrica 300mg capsules
0408010AEBBAGAG
|
Lyrica | Pregabalin | Central Nervous System | 4,402 |
|
Lyrica 150mg capsules
0408010AEBBAEAE
|
Lyrica | Pregabalin | Central Nervous System | 2,932 |
|
Lyrica 75mg capsules
0408010AEBBACAC
|
Lyrica | Pregabalin | Central Nervous System | 2,233 |
|
Lyrica 100mg capsules
0408010AEBBADAD
|
Lyrica | Pregabalin | Central Nervous System | 2,170 |
|
Lyrica 50mg capsules
0408010AEBBABAB
|
Lyrica | Pregabalin | Central Nervous System | 2,056 |
|
Lyrica 200mg capsules
0408010AEBBAFAF
|
Lyrica | Pregabalin | Central Nervous System | 1,500 |
|
Lyrica 25mg capsules
0408010AEBBAAAA
|
Lyrica | Pregabalin | Central Nervous System | 1,361 |
|
Lyrica 225mg capsules
0408010AEBBAHAI
|
Lyrica | Pregabalin | Central Nervous System | 458 |
|
Lyrica 20mg/ml oral solution
0408010AEBBAIAN
|
Lyrica | Pregabalin | Central Nervous System | 224 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.